Authors
Latest:
A New Monoclonal Antibody for R/R MM: Isatuximab-irfcIsatuximab-ifrc is the third monoclonal antibody approved for the treatment of R/R MM.
Latest:
Drug Diversion: New Approaches to an Old ProblemDrug diversion in hospitals continues to be problematic. Heightened DEA activity and opioid addiction reaching epidemic proportions require hospitals to be more vigilant than ever.
Latest:
The Changing Clinical Assessment: An Overview and Next-Level ChallengesThe clinical assessment has long been a cornerstone of patient-centric specialty pharmacy care.
Latest:
Walmart Essay Winner: A Community Pharmacist's Impact Can Go a Long Way"The total time that I spent with this man was less than 20 minutes, but the impact that I had on his life when he thought he was all alone will last a lifetime."
Latest:
Comparative Effectiveness of TNF Blockers in Rheumatoid Arthritis PatientsAmong rheumatoid arthritis patients newly treated with adalimumab, etanercept, or infliximab, lower dose escalation rates and costs were seen with etanercept.
Latest:
Unanticipated Learning Opportunities for Pharmacy Students During COVID-19The coronavirus disease 2019 pandemic has presented pharmacy students with an opportunity to develop new skills that former students never had the opportunity to develop.
Latest:
Biopharmaceuticals: A Way Forward for Biogenerics?Although the demand for generic competition in the biopharmaceutical market could potentially be great, regulators have been slow to clear a pathway for the approval of generic biopharmaceuticals.
Latest:
Specialty Pharmacies May Improve Care for Hemophilia, vWD PatientsTo improve the care of patients with hemophilia and von Willebrand's Disease (vWD), coagulation factor products should be billed through the pharmacy benefit and provided by specialty pharmacies, the authors of a new study suggest.
Latest:
Psoriasis Treatment Patterns: Phototherapy, Oral Nonbiologic, and Biologic TherapiesAmong psoriasis patients initiated on oral nonbiologic or on biologic therapy, most patients undergo at least 1 therapy change within 4 months of treatment initiation.
Latest:
Understanding Predictors of Opioid Abuse: Predictive Model Development and ValidationThis study developed and tested predictive models of opioid abuse using Humana commercial membership data that were subsequently tested in the Truven commercial data set.
Latest:
New on the Job: Dos and Don'tsThese tips can help recent pharmacy school graduates navigate the professional world.
Latest:
Pharmacists Can Tackle Thimerosal Misinformation Through Education, Empathy, and TransparencyAdam James, PharmD, and Chris Altman, PharmD, explain how pharmacists can build trust and reduce vaccine hesitancy by clearly communicating thimerosal’s limited role in today’s immunizations and addressing patient concerns with empathy and education.
Latest:
Medication Management: A Team SportHow do we achieve optimal results for patients? This vision includes strategies and steps for a broader system of care based on the premise that health care professionals cannot go it alone.
Latest:
3 Findings on Colds You May Have MissedThree studies published last year provide useful information on risk factors for colds, which affect adults 2 to 3 times a year.
Latest:
Neuropathic PainNeuropathic pain is a chronic nerve pain that can significantly impair a patient's functioning and quality of life.
Latest:
A Call to Action for Evidence-based, Outcomes-driven Conflict Management StylesWith expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.
Latest:
Web Exclusive: Real-World Anti-TNF Dose Escalation in Patients With Crohn's DiseaseThis study evaluated the rates of dose escalation in patients with Crohn's disease.
Latest:
Clinical Insights: Palforzia is the First FDA-approved Treatment of Peanut AllergyPeanut allergies affect approximately 1.2% of the entire US population and an estimated 2.5% of the childhood population.
